Creutzfeldt-Jakob disease and plasma-derived and urine-derived medicinal products - Scientific guideline

This CHMP reflection paper replaces the CHMP position statement on Creutzfeldt-Jakob disease and plasma-derived and urine-derived medicinal products (EMA/CHMP/BWP/303353/2010).

Keywords: Creutzfeldt-Jakob disease, human transmissible spongiform encephalopathies, plasma-derived medicinal products, urine-derived medicinal products, sporadic CJD, genetic CJD, iatrogenic CJD, variant CJD, blood infectivity, transmissibility

Current version

CHMP reflection paper on Creutzfeldt-Jakob disease and plasma-derived and urine-derived medicinal products - Revision 3

AdoptedReference Number: EMA/CHMP/BWP/303353/2010 Rev 3

Overview of comments received on 'CHMP Reflection paper on Creutzfeldt-Jakob disease and plasma-derived and urine-derived medicinal products - Revision 3

Reference Number: EMA/CHMP/BWP/245922/2024

Draft CHMP position statement on Creutzfeldt-Jakob disease and plasma-derived and urine-derived medicinal products - Revision 3

Consultation dates: 18/10/2018 to 31/10/2019Draft: consultation closedReference Number: EMA/CHMP/BWP/303353/2010 Rev 3

Document history - Revision 2

CHMP position statement on Creutzfeldt-Jakob disease and plasma-derived and urine-derived medicinal products - Revision 2

AdoptedReference Number: EMA/CHMP/BWP/303353/2010Summary:

This CHMP position statement replaces the CHMP position statement on Creutzfeldt-Jakob disease and plasma-derived and urine-derived medicinal products (EMEA/CPMP/BWP/2879/02/rev 1).

Overview of comments received on 'Committee for Medicinal Products for Human Use position statement on Creutzfeldt-Jakob disease and plasma-derived and urine-derived medicinal products'

Reference Number: EMA/CHMP/BWP/782508/2010

Draft CHMP position statement on Creutzfeldt-Jakob disease and plasma-derived and urine-derived medicinal products - Revision 2

Consultation dates: 24/06/2010 to 30/09/2010Draft: consultation closedReference Number: EMEA/CPMP/BWP/2879/02/rev 2

Document history - Revision 1

Concept paper on the need to update the CHMP position statement on CJD and plasma-derived and urine-derived medicinal products (EMEA/CPMP/BWP/2879/02 REV. 1)

Reference Number: EMEA/CHMP/BWP/253246/2009

CHMP position statement on Creutzfeldt-Jacob disease and plasma-derived and urine-derived medicinal products - Revision 1

AdoptedLegal effective date: 23/06/2004Reference Number: EMEA/CPMP/BMP/2879/02/ rev 1

Document history - First version

CPMP position statement on Creutzfeldt-Jakob disease and plasma-derived and urine-derived medicinal products - First version

AdoptedLegal effective date: 20/02/2003Reference Number: EMEA/CPMP/BWP/2879/02

CPMP position statement on new variant CJD and plasma-derived medicinal products - Superseded by CPMP/BWP/2879/02

Legal effective date: 25/02/1998Reference Number: CPMP/201/98